Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Omada Health (OMDA) Change in Receivables (2024 - 2026)

Omada Health's Change in Receivables history spans 2 years, with the latest figure at -$7.2 million for Q4 2025.

On a quarterly basis, Change in Receivables fell 721.7% to -$7.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $968000.0, a N/A change, with the full-year FY2025 number at $12.4 million, up 40.34% from a year prior.
Change in Receivables hit -$7.2 million in Q4 2025 for Omada Health, down from $9.2 million in the prior quarter.
Over the last five years, Change in Receivables for OMDA hit a ceiling of $9.2 million in Q3 2025 and a floor of -$7.2 million in Q4 2025.